Jim Geraghty

Jim Geraghty serves as the Chairman of OMass Therapeutics since May 2023 and holds multiple board chair positions at Orchard Therapeutics and Pieris Pharmaceuticals, alongside a directorship at Fulcrum Therapeutics and Voyager Therapeutics, Inc. Previously, Jim Geraghty was an Entrepreneur in Residence at Third Rock Ventures and held senior leadership roles at sanofi-aventis and Genzyme. Educationally, Jim Geraghty earned a Doctor of Law (J.D.) from Yale Law School, a Master of Science (MS) in Psychology from the University of Pennsylvania, and a Bachelor of Arts (B.A.) in English Literature from Georgetown University.